Larry Goldstein, MD

Chair, Dept of Neurology, University of Kentucky

[Larry Goldstein, MD @LBGoldsteinMD]

My highlighhts from the Clinical Trials session at the AAN Annual Meeting in Chicago.
https://t.co/z8TW5TxhFq

@UKYNeuroscience @UKHealthcare @NeuroUky @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

As compiled by Stanford University in a partnership with Elsevier, two University of Kentucky Neurology faculty  were among the top 2% of the most-cited researchers across 22 disciplines worldwide Dr. Gregory Jicha and myself. @UKYNeuroscience @UKHealthcare @NeuroUky @AANmember

[Larry Goldstein, MD @LBGoldsteinMD]

Advocating for AAN with Sen. Paul @UKHealthcare @NeuroUky @AANMember #NOH26 #AANadvocacy

[Larry Goldstein, MD @LBGoldsteinMD]

On Capitol Hill advocating for Neurology and our patients on a cold day in Washington. @UKHealthcare @NeuroUky @AANMember #NOH26 #AANadvocacy

[Larry Goldstein, MD @LBGoldsteinMD]

In the halls of Congress for the AAN. @UKHealthcare @NeuroUky @AANMember #NOH26 #AANadvocacy

[Larry Goldstein, MD @LBGoldsteinMD]

Post ISC Early Career Session Interview panel

https://t.co/3ONhGod4my

#ISC26 @UKYNeuroscience @UKHealthcare @NeuroUky @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

Read our report in Neurology: Education on secondary trauma in third year medical students in the setting of combined Neurology/Emergency Medicine clerkship. https://t.co/aRPbq1N0S0

@UKYNeuroscience @UKHealthcare @NeuroUky @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

Celebrating 60 Years of Neurology at the University of Kentucky! https://t.co/NHvKm1o9jU @UKYNeuroscience @UKHealthcare @NeuroUky @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

Read my interview on the new AAN Policy Statement on Novel Therapeutics in Neurology Today. https://t.co/rpeAfQhoZa @UKYNeuroscience @UKHealthcare @NeuroUky @AANmember

[Larry Goldstein, MD @LBGoldsteinMD]

AAN provides guidance for non-FDA approved neuro therapies in position statement https://t.co/yOYm5qdWA6. @UKYNeuroscience @UKHealthcare @NeuroUky @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

New Guidance on the Use of Unproven Neurologic Therapeutics - Read our interview on Medscape https://t.co/DJvOGnom22 https://t.co/DJvOGnom22 @UKYNeuroscience @ukhealthcare @NeuroUky @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

New Guidance on the Use of Unproven Neurologic Therapeutics
https://t.co/DJvOGnom22 https://t.co/DJvOGnom22 @UKYNeuroscience @UKHealthcare
@NeuroUky @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

Read our new AAN Position Statement on Novel Therapeutics. https://t.co/NqKqJjor4I @UKYNeuroscience
@UKHealthcare @NeuroUK @NeurologyUK @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

Watch the Stroke Care Network’s video on pre-hospital stroke care. https://t.co/C8Eau6sMej @UK_HealthCare @UKYneuroscience @NeuroUky @AANmember

[Larry Goldstein, MD @LBGoldsteinMD]

Interview following 2025 Annual AAN Meeting.

https://t.co/8lF9XuPLTn

@UK_HealthCare @UKYneuroscience @NeuroUky @AANmember

[Larry Goldstein, MD @LBGoldsteinMD]

AAN Kentucky on the hill #NOH25 #AANadvocacy @AANmember

[Larry Goldstein, MD @LBGoldsteinMD]

Neurology on the Hill. Congressman McGarvey#NOH25 #AANAdvocacy @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

Neurology on the Hill. Congressman Barr #NOH25 #AANAdvocacy @AANMember

[Larry Goldstein, MD @LBGoldsteinMD]

AAN Neurology on the Hill - Kentucky #NOH25 #AANadvocacy @AANmember

[Larry Goldstein, MD @LBGoldsteinMD]

Read my commentary on a report on an association between NSAID “allergy” and cardiovascular risk. @UK_HealthCare @UKYneuroscience @NeuroUky @AANmember @GoHealio https://t.co/YeUYCRg0B3